Synergistic potentiating effect of D(+)-mannose, orotic, and hippuric acid sodium salt on selective toxicity of a mixture of 13 substances of the circulatory system in culture for various tumor cell lines.
Despite global immune system abnormalities in the autoimmune deficiency syndrome, the incidence of only a few tumor types increases, and the degree of immunosuppression does not seem to be critical in the development of these tumors, indicating that the immune system does not prevent tumor development. Consequently, because tumors do not develop in most individuals, other defense systems may exist. We demonstrated previously that 13 substances in the circulatory system acting synergistically induced apoptosis in vitro and in vivo in different tumor cell lines, but not in normal cells and animals. We investigated another 17 compounds and five ions in the circulatory system to determine their participation in the defense provided by the 13 substances. Three of the 17 substances but no ions had a potentiating effect on the mixture of substances used previously. The new 16-component mixture suppressed in vitro growth of six human and murine tumor cell lines, including multidrug-resistant tumor cells, without cytotoxic effects in two normal cell lines. The selectivity also was demonstrated by investigating the mixture's effect over time on tumor and normal cell growth.
Kulcsár
G
G
Institute of Biochemistry, University Medical School of Pécs, Hungary.
D000818:Animals; D000970:Antineoplastic Agents / Q000097:blood*; D000971:Antineoplastic Combined Chemotherapy Protocols / Q000494:pharmacology*; D002455:Cell Division / Q000187:drug effects; D002460:Cell Line / Q000187:drug effects; D003124:Colorimetry; D004285:Dogs; D018432:Drug Resistance, Multiple; D006626:Hippurates / Q000008:administration & dosage / Q000494:pharmacology; D006801:Humans; D008253:Macaca mulatta; D008358:Mannose / Q000008:administration & dosage / Q000494:pharmacology; D051379:Mice; D009101:Multiple Myeloma / Q000188:drug therapy / Q000473:pathology; D009374:Neoplasms, Experimental / Q000188:drug therapy* / Q000276:immunology / Q000473:pathology; D009963:Orotic Acid / Q000008:administration & dosage / Q000494:pharmacology; D013778:Tetrazolium Salts; D013844:Thiazoles; D014407:Tumor Cells, Cultured / Q000187:drug effects
D000970:Antineoplastic Agents; D006626:Hippurates; D013778:Tetrazolium Salts; D013844:Thiazoles; D009963:Orotic Acid; C022616:thiazolyl blue; D008358:Mannose; C030514:hippuric acid